Lv11
20 积分 2024-03-06 加入
The present and future of bispecific antibodies for cancer therapy
4小时前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
20天前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
20天前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
20天前
已完结
Nanobody–antigen interaction prediction with ensemble deep learning and prompt-based protein language models
1个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
1个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
1个月前
已完结
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer
1个月前
已完结
Deep Generative Models for Therapeutic Peptide Discovery: A Comprehensive Review
5个月前
已完结
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
8个月前
已完结
皖公网安备34019202002308
